Charles Schwab
RVLP

Charles Schwab’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History

Charles Schwab’s Portfolio RVLP Stock Details RVLP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-13,322
Closed -$7.46K – 3666
2023
Q2 		$7.46K Hold
13,322
– – ﹤0.01% 3601
2023
Q1 		$15.2K Hold
13,322
– – ﹤0.01% 3527
2022
Q4 		$14.9K Hold
13,322
– – ﹤0.01% 3518
2022
Q3 		$28K Sell
13,322
-19,391
-59% -$37.7K ﹤0.01% 3451
2022
Q2 		$45K Hold
32,713
– – ﹤0.01% 3407
2022
Q1 		$56K Buy
+32,713
New +$46.8K ﹤0.01% 3515
2021
Q3 		– Sell
-61,991
Closed -$187K – 3558
2021
Q2 		$187K Sell
61,991
-23,870
-28% -$73.1K ﹤0.01% 3272
2021
Q1 		$280K Buy
85,861
+3,349
+4% +$13.8K ﹤0.01% 3263
2020
Q4 		$340K Sell
82,512
-12,465
-13% -$71.8K ﹤0.01% 3111
2020
Q3 		$514K Buy
94,977
+3,644
+4% +$21K ﹤0.01% 2872
2020
Q2 		$615K Buy
91,333
+26,181
+40% +$128K ﹤0.01% 2760
2020
Q1 		$208K Buy
65,152
+26,778
+70% +$143K ﹤0.01% 3006
2019
Q4 		$269K Sell
38,374
-2,788
-7% -$14.9K ﹤0.01% 2996
2019
Q3 		$159K Buy
41,162
+2,064
+5% +$6.99K ﹤0.01% 3066
2019
Q2 		$149K Buy
39,098
+392
+1% +$1.3K ﹤0.01% 3108
2019
Q1 		$140K Buy
38,706
+632
+2% +$4.65K ﹤0.01% 3065
2018
Q4 		$296K Buy
+38,074
New +$305K ﹤0.01% 2941

Other funds holding RVLP

ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
TAM
Titleist Asset Management San Antonio, Texas $1.49B AUM 22.27% 1-Year Est. Return

Charles Schwab's RVLP Position: Q3 2023 in Review

Charles Schwab sold out of RVL Pharmaceuticals plc Ordinary Shares (RVLP) in Q3 2023, closing a stake of 13,322 shares — an estimated $7.46K sold.

Charles Schwab first reported a position in RVLP in Q4 2018 and held it in 17 quarters. The position peaked at $615K in Q2 2020. 32 funds tracked by Wall St. Rank hold RVLP as of Q3 2023.

  • Charles Schwab reported no remaining RVL Pharmaceuticals plc Ordinary Shares position as of Q3 2023 after selling out during the quarter.
  • Charles Schwab sold 13,322 RVL Pharmaceuticals plc Ordinary Shares shares in Q3 2023, an estimated $7.46K.
  • Charles Schwab first reported a position in RVL Pharmaceuticals plc Ordinary Shares in Q4 2018 and held it in 17 quarters.
  • Charles Schwab's RVL Pharmaceuticals plc Ordinary Shares position peaked at $615K in Q2 2020.
  • 32 funds tracked by Wall St. Rank held RVL Pharmaceuticals plc Ordinary Shares as of Q3 2023.

Based on Charles Schwab's 13F filing for Q3 2023, filed 8 Nov 2023.